Oocyte number and quality decline with age; however, fertility varies significantly even
among women of the same age. Various measures have been developed to predict …

Many strategies have been proposed to manage poor responder patients, however, a
consensus upon which is the most beneficial has not been yet reached. DuoStim is the most …

STUDY QUESTION What is the cumulative delivery rate (CDR) per aspiration IVF/ICSI cycle
in low-prognosis patients as defined by the Patient-Oriented Strategies Encompassing …

Objective To compare new automated antimüllerian hormone (AMH) assay performance
characteristics from the new automated Elecsys AMH (Roche; Elecsys) and Access AMH …

Introduction Fertility is referred to the capability for having offspring and can be evaluated by
fertility rate. Women's fertility is strictly dependent on individual's age. The fertility peak …

Purpose To evaluate the potential application of a nomogram based on woman's age and
ovarian reserve markers as a tool to optimize the follicle-stimulating hormone (FSH) starting …

The POSEIDON group (P atient-O riented S trategies E ncompassing I ndividualize DO ocyte
N umber) has introduced “the ability to retrieve the number of oocytes needed to achieve at …

Objective: The objective of the study was to evaluate whether anti-Müllerian hormone (AMH)
is associated with fecundability among women with proven fecundity and a history of …

This multicenter study evaluated the reliability of the recently published ART calculator for
predicting the minimum number of metaphase II (MII) oocytes (MIImin) to obtain at least one …

Objective To estimate the prevalence of low-prognosis patients according to the POSEIDON
criteria using real-world data. Design Multicenter population-based cohort study. Settings …